![Stacey Liekweg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Stacey Liekweg has held positions as President & Director at Immunovalent Therapeutics, Inc. and Chief Operating Officer at Caelivascular, Inc.
Cargos activos de Stacey Liekweg
Empresas | Cargo | Inicio |
---|---|---|
Immunovalent Therapeutics, Inc.
![]() Immunovalent Therapeutics, Inc. BiotechnologyHealth Technology Immunovalent Therapeutics, Inc. is a medicine company harnessing microfluidic technology for the treatment of cancer immunotherapy. The company is headquartered in St. Louis, MO. | Presidente | - |
Caelivascular, Inc.
![]() Caelivascular, Inc. Medical SpecialtiesHealth Technology CaeliVascular, Inc. is a medical company that specializes in developing innovative catheters for vascular surgery. The company is based in St. Louis, MO. The company's focus is on transforming the treatment of deep vein thrombosis and pulmonary embolism. The CEO of the company is John Hardin. | Director de Operaciones | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Immunovalent Therapeutics, Inc.
![]() Immunovalent Therapeutics, Inc. BiotechnologyHealth Technology Immunovalent Therapeutics, Inc. is a medicine company harnessing microfluidic technology for the treatment of cancer immunotherapy. The company is headquartered in St. Louis, MO. | Health Technology |
Caelivascular, Inc.
![]() Caelivascular, Inc. Medical SpecialtiesHealth Technology CaeliVascular, Inc. is a medical company that specializes in developing innovative catheters for vascular surgery. The company is based in St. Louis, MO. The company's focus is on transforming the treatment of deep vein thrombosis and pulmonary embolism. The CEO of the company is John Hardin. | Health Technology |
- Bolsa de valores
- Insiders
- Stacey Liekweg